We are pleased to announce the launch of our first quarterly ZIKAction newsletter, which was born from the collaboration with the other EU funded ZIKA consortia: ZIKAlliance and ZIKA PLAN. Hope you enjoy it!
Within the ZIKA-PATHO work package of ZIKAction, Dr. Maureen Long and her lab at the University of Florida have developed a sheep model of mother-to-child Zika virus transmission. Fetal sheep have proven to be an excellent model of fetal stress in human pregnancies, highly succeptible to early viral infection and demonstrating brain and limb defects in association with these infections.
ZIKAction visited the West African country of Cape Verde, which last year experienced an outbreak of Zika virus (ZIKV). The hospital personnel in Praia, the capital of Santiago – main-island warmly welcomed the ZIKAction team and are eager to contribute their first-hand experience with and knowledge of ZIKV infection in pregnancy to ZIKAction activities.
By Calvet GA, Kara EO, Giozza SP, et al. Zika virus (ZIKV) has been identified in several body fluids of infected individuals. In most cases, it remained detected in blood from few days to 1 week after the onset of symptoms, and can persist longer in urine and in semen. ZIKV infection can have dramatic consequences such as microcephaly… Read More »
We are excited to begin enrollment in the prospective cohort study of mother-to-child transmission of Zika (ZIKV), Dengue (DENV) and Chikungunya (CHIKV) virus infection, having received ethics approval in Jamaica on April 5.
By Christie CDC, Palmer PM, Tomlinson J., Green-Douglas T., Hamilton M., Pierre RB., Hylton-Kong T., Morgan O., Barrow G., Mitchell P., Skyers N., Stevens E-J., Condell-Gibson N, Harvey KM.
Jamaica is an upper middle-income developing Caribbean island-nation, population 2.8 million, with a generalized and mixed HIV epidemic. We report progress towards achieving international validation standards for the elimination of vertical transmission of HIV and syphilis in Jamaica during 2013 through 2015.
Published in: Annals of Public Health and Research 2017:4(2);1091-9.
By Halai UA, Nielsen-Saines K, Moreira ME, Sequeira PC, Pereira Junior JP, Zin AA, Cherry JD, Gabaglia CR, Gaw SL, Adachi K, Tsui I, Pilotto JH, Ribeiro Nogueira RM, Bispo de Filippis AM, Brasil P.
Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies or abnormal pregnancy/infant outcomes.
Members of ZIKAction, ZIKAlliance and ZikaPLAN participated in a cross-consortia meeting in Heidelberg, Germany this February to allign technical aspects of data collection and quality control for the ZIKA-VT mother-to-child transmission prospective cohort study.
After remaining related to few sporadic cases in limited regions for more than half century since its discovery, Zika virus (ZIKV) was recently introduced into the Western Hemisphere, first in Brazil and then spreading very rapidly in the Americas. Unexpectedly, an increased incidence of microcephaly and other neurologic malformations in fetuses born to mothers infected with ZIKV during pregnancy was reported in Brazil, leading the World Health Organization to declare this situation a Public Health Emergency of International Concern
Published in: Pediatr Infect Dis J. 2017 Mar;36(3):333-336. doi: 10.1097/INF.0000000000001449.
By clicking “Accept All” you agree to receive ALL cookies on our Website.
You can reject the cookies that are not “technical and necessary” customizing your choices by clicking on “Cookie settings”.
If you close this banner by clicking the "X" button, default settings will remain in place and you will continue to browse the Website only with “technical and necessary cookies”.
You can review and change your choices at any time by accessing the Management consent panel.